Inhaled Insulin

Positive data reported from trial of Alveair insulin pulmonary technology

Published in Obesity and Diabetes Week, February 16th, 2004

Coremed, Inc., announced positive data from the first human trial of its "needle-less" Alveair insulin pulmonary technology.

The technology uses a hand-held device that delivers inhaled insulin with the same units as conventionally injected insulin.

A small number of normal humans were involved in the clinical trial. Alveair insulin was administered exactly like the current clinical practice of insulin injection. The only difference is that, in this case, humans in the trial inhaled Alveair insulin without any need to use a needle.

The trial was administered with a single dose, two periods crossover design, with an in-between...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week

Source: Obesity and Diabetes Week (2004-02-16)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry